Advertisement

HIV/AIDS Clinical Care

HIV/AIDS Clinical Care

HIV and ID Observations Blog

CDC Recommends Broader Use of Pre-Exposure Prophylaxis — Can We Make It Happen? Free

CDC is now recommending tenofovir/FTC (Truvada) for all Americans at high risk for HIV. Dr. Paul Sax offers his thoughts on the challenges ahead.

Guideline Watch

CDC Guidelines for Pre-Exposure Prophylaxis to Prevent HIV Infection

Daily oral tenofovir/FTC coupled with risk-reduction services and careful monitoring is recommended as one prevention option for high-risk men who have sex with men, heterosexuals, and injection-drug users.

Updated DHHS HIV Treatment Guidelines

This major revision includes a recommendation for less-frequent CD4-count monitoring, an updated list of recommended regimens, a discussion of “switching,“ and a new section on treatment costs.

Managing Drug Interactions in the Treatment of HIV-Associated TB

These updated guidelines provide recommendations for managing drug interactions between rifamycin antibiotics and four classes of antiretrovirals and for co-treatment of tuberculosis and HIV infection in children and pregnant women.

Prevention of Catheter-Associated Urinary Tract Infections

This document updates 2008 guidelines on prevention of catheter-associated urinary tract infections in acute care hospitals.

Drug Watch

Dolutegravir

The FDA has approved the integrase inhibitor dolutegravir for treatment of HIV infection, in combination with other antiretrovirals.